Theseus Pharmaceuticals (THRX) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	93.19M
Marketable securities
Accounts receivable from related party
Notes receivable
Prepaid expenses and other current assets	534K
Total current assets	186.12M
Restricted cash
Property and equipment, net	381K
Notes receivable
Other assets	40K
Total assets	370.54M
Accounts payable	528K
Accrued personnel-related expenses	1.63M
Accrued clinical and development expenses
Accrued interest on convertible subordinated notes	6.61M
Other current liabilities	1.73M
Note payable and capital lease, current
Deferred revenue, current	885K
Total current liabilities	14.92M
Convertible subordinated notes	241.54M
Deferred rent, non-current
Note payable and capital lease, non-current
Deferred revenue	2.44M
Commitments and contingencies (Notes 4, 8 and 9)	0
Stockholders' net capital deficiency:
Additional paid-in capital	1.29B
Accumulated other comprehensive income (loss)	8K
Accumulated deficit	-1.66B
Total stockholders' net capital deficiency
Total liabilities and stockholders' net capital deficiency	370.54M
Stockholders' net capital deficiency:
Common stock	1.1M
Stockholders' net capital deficiency:
Common stock

Entities mentioned with THRX

View All Entities